Liver failure, transplantation, and critical care

Critical Care Clinics

Volumn 19, Issue 2, 2003, Pages 155-183

  Krasko, Anatoli ^a,b,c   Deshpande, Kedar ^a,b,c   Bonvino, Steven ^a,c  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b JACOBI MEDICAL CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AZATHIOPRINE; BASILIXIMAB; BILIRUBIN; BREQUINAR; CHLORDIAZEPOXIDE; DACLIZUMAB; DIAZEPAM; IMMUNOSUPPRESSIVE AGENT; LORAZEPAM; MERCAPTOPURINE; MIZORIBINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY T10B9.1A 31; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; ORTHOCLONE; OXAZEPAM; PETHIDINE; PREDNISONE; RAPAMYCIN; SIMULEC; T10B9.1A 31; TACROLIMUS; UNCLASSIFIED DRUG;

ASCITES; BLOOD CLOTTING DISORDER; BRAIN DISEASE; CARDIOVASCULAR FUNCTION; CHILD TURCOTTE PUGH SCORING SYSTEM; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG METABOLISM; GENE THERAPY; GRAFT REJECTION; HEPATOPULMONARY SYNDROME; HEPATORENAL SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTENSIVE CARE; INTERNATIONAL STANDARD UNIT; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER PERFUSION; LIVER TRANSPLANTATION; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PREOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY FAILURE; REVIEW; SCORING SYSTEM; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VARICOSIS;

CHILD, PRESCHOOL; CRITICAL CARE; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; PREOPERATIVE CARE; SEVERITY OF ILLNESS INDEX;

EID: 0037379424     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(02)00051-9     Document Type: Review

References (138)

1. Welch CS. A note on transplantation of the whole liver in dogs. Transplantation Bulletin 1955;2:54.
2. Cannon JA. Brief report. Transplantation Bulletin 1956;3:7.
3. Moore FD, Birtch AG, Dagher F, et al. Immunosuppression and vascular insufficiency in liver transplantation. Ann N Y Acad Sci 1964;102:729.
4. Starzl TE, Kaupp Jr HA, Brock DR, et al. Reconstructive problems in canine liver homotransplantation with special reference to the postoperative role of hepatic venous flow. Surg Gynecol Obstet 1960;111:733.
5. Starzl TE. History of liver and other splanchnic organ transplantation. In: Busuttil RW, Klintmalm GB, editors. Transplantation of the liver. Philadelphia: WB Saunders; 1996. p 3.
6. Starzl TE, Marchioro TL, Von Kaulla KN, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963;117:659.
7. Keeffe EB. Liver transplantation at the millennium: past, present, and future. Clin Liver Dis 2000;4(1):241-55.
8. Iwatsuki S, Starzl TE, Todd S, et al. Experience in 1,000 liver transplants under cyclosporinesteroid therapy: a survival report. Transplant Proc 1988;20(Suppl 1):498.
9. Calne RY, Rolles K, White DJG, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaver organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979;2:1033.
10. Calne RY, White DJ, Rolles K, et al. Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet 1978;1:1183.
11. Kino T, Hatanaka H, Hashimoto M, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. 1. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) 1987;40:1249-55.
12. Kino T, Hatanaka H, Miyata S, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 1987;40:1256-65.
13. European FK506 Multicenter Liver Study Group. Randomized trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 1994;344:423-4.
14. Fung JJ, Eliasziw M, Todo S, et al. The Pittsburgh randomized trial of tacrolimus vs cyclosporine for liver transplantation. J Am Coll Surg 1996;183:117-25.
15. Fung JJ, Todo S, Abu-Elmagd K, et al. Randomized trial in primary liver transplantation under immunosuppression with FK506 or cyclosporine. Transplant Proc 1993;25:1130.
16. Starzl TE, Donna A, Eliasziw M, et al. Randomized trialomania?: the multicenter liver transplant trials. Lancet 1995;346:1346-50.
17. The US Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) with cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994;331:1110-5.
18. Chatenoud L, Baudrihaaye MF, Chkoff N, et al. Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3. J Immunol 1986;137:830.
19. Kirkman RL, Shapiro ME, Carpenter CB, et al. A randomized trial of the anti-tac monoclonal antibody in human renal transplantation. Transplantation 1991;51:107-13.
20. Nashan B, Moore R, Amlot P, et al. Randomized trial of basilizimab versus placebo for control of acute rejection in renal allograft recipients. Lancet 1997;350:1193-7.
21. Vincenti F, Kirkman R, Light S, et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. N Engl J Med 1998;338:161-5.
22. Jain AB, Hamad I, Rakela J, et al. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. Transplantation 1998;66(10):1395-8.
23. Jain A, Khanna A, Molmenti EP, et al. Immunosuppressive therapy: new concepts. Surg Clin N Am 1999;79(1):59-76.
24. Cacciarelli TV, Keeffe EB, Moore DH, et al. Primary liver transplantation without transfusion of red blood cells. Surgery 1996;120:698.
25. Shaw Jr BW, Martin DJ, Marquez JN, et al. Venous bypass in clinical liver transplantation. Ann Surg 1984;200:524.
26. Verran DJ, Asfar SK, Ghent CN, et al. Biliary reconstruction without T-tubes or stents in liver transplantation: report of 502 consecutive cases. Liver Transpl Surg 1997;3:365.
27. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338(24):1741-51.
28. United Network for Organ Sharing. http://www.unos.org (updated 2002; Accessed May 2002)
29. Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997;3:628-37.
30. Dickson ER, Grambsch PM, Flemming TR, et al. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989;10:1-7.
31. Saab S, Han SH, Martin P. Liver transplantation. Selection, listing criteria, and preoperative management. Clin Liver Dis 2000;4(3):513-32.
32. Krowka MJ, Porayko MK, Plevak DJ, et al. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc 1997;72:44-53.
33. Schiodt FV, Atillasoy E, Shakil AO, et al. 0Etiology and prognosis for 295 patients with acute liver failure in the US. Gastroenterology 1997;122:A1376.
34. Shakil AO, Mazariegos GV, Kramer DJ. Fulminant hepatic failure. Surg Clin N Am 1999;79(1):77-108.
35. Strauss G, Adel-Hansen B, Kirkegaard P, et al. Liver function, cerebral blood flow autoregulation, and hepatic encephalopathy in fulminant hepatic failure. Hepatology 1997;25:837-9.
36. Butterworth RF, Giguere JF, Michand J, et al. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987;6:1-12.
37. Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet 1971;2:75-80.
38. Hadesman R, Wiesner RH, Go VL. Concentrations of 3,4-dihydroxyphenylalanine and catecholamines and metabolites in brain in an an hepatic model of hepatic encephalopathy. J Neurochem 1995;65:1166-75.
39. Mans AM, DeJoseph MR, Hawkins RA. Metabolic abnormalities and grade of encephalopathy in acute hepatic failure. J Neurochem 1994;63:1829-38.
40. Michalak A, Rose C, Butterworth J, et al. Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure. Hepatology 1996;24:908-13.
41. Michalak A, Rose C, Buu PN, et al. Evidence for altered central noradrenergic function in experimental acute liver failure in the rat. Hepatology 1998;27:362-8.
42. Mullen KD, Szauter KM, Kaminsky-Russ K. "Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet 1990;376:81-3.
43. Wendon JA, Harrison PM, Keays R, et al. Cerebral blood flow and metabolism in fulminant hepatic failure. Hepatology 1994;19:1407-13.
44. Shah V, Webster S, Gottstein J, et al. Reduction of cerebral perfusion precedes rise of intracranial pressure in rats with ischemic fulminant liver failure. Hepatology 1993;17:1117-22.
45. Ware AJ, D'Agostino AN, Combes B. Cerebral edema: a major complication of massive hepatic necrosis. Gastroenterology 1971;61:877.
46. Baudouin SV, Howdle P, O'Grady JG, et al. Acute lung injury in fulminant hepatic failure following paracetamol poisoning. Thorax 1995;50:399-402.
47. Bihari D, Gimson AE, Waterson M, et al. Tissue hypoxia during fulminant hepatic failure. Crit Care Med 1985;13:1034-9.
48. Riordan SM, Williams R. Fulminant hepatic failure. Clin Liver Dis 2000;4(1):25-45.
49. Bihari DJ, Gimson AES, Williams R. Cardiovascular, pulmonary and renal complications of fulminant hepatic failure. Semin Liver Dis 1986;6:119-28.
50. Harrison PM, Wendon JA, Williams R. Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure. Hepatology 1996;23:1067-72.
51. Ring-Larsen H, Palazzo U. Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis. Gut 1981;22:585.
52. McCullough AJ, Tavill AS. Disordered protein and energy metabolism in liver disease. Semin Liver Dis 1991;11:265-77.
53. Fryburg DA, Barrett EJ. Insulin, growth hormone and IGF-1 regulation of protein metabolism. Diabetes Reviews 1995;3:93-112.
54. Mammen EF. Coagulation abnormalities in liver disease. Hematol Oncol Clin N Am 1992;6:1247-57.
55. Espiritu JD. Pulmonary embolism in a patient with coagulopathy from end-stage liver disease. Chest 2000;117(3):924-5.
56. Castelino DJ, Salem HH. Natural anticoagulants and the liver. J Gastroenterol Hepatol 1997;12:77-83.
57. Vianna A, Hayes PC, Moscoso G. Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology 1987;93:876.
58. Garcia-Tsao G, Groszmann R, Fisher RL, et al. Portal pressures, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5:419.
59. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332.
60. Smith JL, Graham DY. Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology 1982;82:968.
61. Rubin RA, O'Brien C, Haskal ZJ, et al. Decreased survival following transjugular intrahepatic portosystemic shunting for Child C patients with high Apache II scores. Am J Gastroenterol 1995;90:556.
62. Runyon BA. Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. Hepatology 1990;12:710-5.
63. Wong F, Blendis L. Hepatorenal failure. Clin Liver Dis 2000;4(1):169-89.
64. Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology 1994;20:1343-50.
65. Sherlock S. Vasodilatation associated with hepatocellular disease: relation to functional organ failure. Gut 1990;31:365-7.
66. Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996;23:164-76.
67. Krowka MJ, Tajik AJ, Dickson ER, et al. Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates: screening by two-dimensional contrast-enhanced echocardiography. Chest 1990;97:1165-70.
68. Scott V, Dodson F, Kang Y. The hepatopulmonary syndrome. Surg Clin North Am 1999;79(1):23-41.
69. Berthelot P, Walker JG, Sherlock S, et al. Arterial changes in the lungs in cirrhosis of the liverlung spider nevi. N Engl J Med 1966;274:291-8.
70. Rydell R, Hoffbauer FW. Multiple pulmonary arteriovenous fistulae in juvenile cirrhosis. Am J Med 1956;21:450-9.
71. Nakamura T, Nakamura S, Tazawa S, et al. Measurement of blood flow through portopulmonary anastomosis in portal hypertension. J Lab Clin Med 1965;65:114-21.
72. Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995;122:521-9.
73. Goetting MG, Preston G. Jugular bulb catheterization: experience with 123 patients. Crit Care Med 1990;18:1220.
74. Aggarwal S, Kang Y, DeWolf A, et al. Transcranial Doppler: monitoring of cerebral blood flow velocity during liver transplantation. Transplant Proc 1993;25(2):1799-800.
75. Davenport A, Will EJ, Davison AM. Effect of posture on intracranial pressure and cerebral perfusion pressure in patients with fulminant hepatic and renal failure after acetaminophen selfpoisoning. Crit Care Med 1990;18:286.
76. Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. Gastroenterology 1977;72:573-83.
77. Lowenstein DH, Aminoff MJ, Simon RP. Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients. Neurology 1988;38:395.
78. Als-Nielsen B, Kjaergard LL, Gluud C. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy. (Cochrane Review). In: The Cochrane Library, 2002;(4):CD002798.
79. Nemeto EM, Klementavicus R, Melick JA, et al. Suppression of metabolic rate for oxygen (CMRO2) by mild hypothermia compared with thiopental. J Neurosurg Anesthesiol 1996;8:52.
80. Rozga J, Podesta L, LePage L, et al. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 1993;342:898-9.
81. Doyle HR, Marino IR, Miro A, et al. Adult respiratory distress syndrome secondary to endstage liver disease: successful outcome following liver transplantation. Transplantation 1993;55:292-6.
82. Holmes CL, Patel BM, Russell JA, et al. Physiology of vasopressin relevant to management of septic shock. Chest 2001;120(3):989-1002.
83. Harrison PM, Wendon JA, Gimson AES, et al. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991;324:1852-7.
84. Davenport A, Will EJ, Losowsky MS, et al. Continuous arteriovenous hemofiltration in patients with hepatic encephalopathy and renal failure. BMJ 1987;295:1028.
85. Badalamenti S, Graziani G, Salerno F, et al. Hepatorenal syndrome. New perspectives in pathogenesis and treatment. Arch Intern Med 1993;153:1957-67.
86. Guevara M, Gines P, Fernandez-Esparrach G, et al. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 1998;27:35-41.
87. Rosemurgy AS, Goode SE, Zwiebel BR, et al. A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg 1996;224:378.
88. Qiu JG, Delany HM, Teh EL, et al. Contrasting effects of identical nutrients given parenterally or enterally after 70% hepatectomy: bacterial translocation. Nutrition 1997;13(5):431-7.
89. Plauth M, Merli M, Kondrup J, et al. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 1997;16:43-5.
90. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically patients: systematic review of randomised controlled trials. BMJ 1998;317:235-40.
91. Runyon BA. Albumin infusion for spontaneous bacterial peritonitis. Lancet 1999;354:1838-9.
92. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-9.
93. O'Grady JG, Alexander GJM, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-45.
94. Pauwels A, Mostefa-Kara N, Florent C, et al. Emergency liver transplantation for acute liver failure: evaluation of London and Clichy criteria. J Hepatol 1993;17:124.
95. Mitchell I, Bihari D, Chang R, et al. Earlier identification of patients at risk from acetaminophen-induced acute liver failure. Crit Care Med 1998;26:279.
96. Bernuau J, Samuel D, Durand F, et al. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V below 50% of normal: a prospective study. Hepatology 1991;14:49A.
97. Maguire PJ, Stevens C, Humes HD, et al. Bioartificial organ support for hepatic, renal, and hematologic failure. Crit Care Clin 2000;16(4):681-94.
98. Wachs M, Bak T, Karrer F, et al. Adult living donor liver transplantation using a right hepatic lobe. Transplantation 1998;66:1313.
99. Ash SR. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif Organs 1994;18:355.
100. Ellis AJ, Hughes RD, Nicholl D, et al. Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the BioLogic-DT. Int J Artif Organs 1999;22:27.
101. Gerlach JC. Development of a hybrid liver support system: a review. Int J Artif Organs 1996;19:645.
102. Thiese ND. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000;31:235.
103. Horslen SP, Hammel JM, Fristoe LW, et al. Extracorporeal liver perfusion using human and pig livers for acute liver failure. Transplantation 2000;70(10):1472-8.
104. Chowdhury JR. Forward: prospects of liver cell transplantation and liver-directed gene therapy. Semin Liver Dis 1999;19:1.
105. Strom SC, Chowdhury JR, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 1999;19(1):39-48.
106. Morgan DJ, McLean AL. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. Clin Pharmacokinet 1995;29(5):370.
107. Volles DF, McGory R. Pharmacokinetic considerations. Crit Care Clin 1999;15(1):55-75.
108. Mazariegos GV, Molmenti EP, Kramer DJ. Early complications after orthotopic liver transplantation. Surg Clin N Am 1999;79(1):109-29.
109. Spanier TB, Klein RD, Nasraway SA, et al. Multiple organ failure after liver transplantation. Crit Care Med 1995;23:466-73.
110. Campellone JV, Lacomis D, Kramer DJ, et al. Acute myopathy following liver transplantation. Neurology 1998;50:46-53.
111. Torres A, Ewing S, Insausti J, et al. Etiology and microbial patterns of pulmonary infiltrates in patients with orthotopic liver transplantation. Chest 2000;117(2):494-502.
112. O'Brien JD, Ettinger NA. Pulmonary complications of liver transplantation. Clin Chest Med 1996;17:99-114.
113. Biancofiore G, Romanelli AM, Bindi ML, et al. Very early tracheal extubation without predetermined criteria in a liver transplant recipient population. Liver Transpl 2001;7(9):777-82.
114. Yost CS, Matthay MA, Gropper MA. Etiology of acute pulmonary edema during liver transplantation: a series of cases with analysis of the edema fluid. Chest 2001;119(1):219-23.
115. Singh N, Gayowski T, Wagener M, et al. Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. Transplantation 1994;58(7):774-8.
116. Aggarwal S, Kang Y, Freeman JA, et al. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc 1987;19(Suppl 3):54-5.
117. Aggarwal S, Kang Y, Freeman JA, et al. Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J Crit Care 1993;8:154-60.
118. DeWolf A, Scott V, Bjerke R, et al. Hemodynamic effects of inhaled nitric oxide in four patients with severe liver disease and pulmonary hypertension. Liver Transplant Surg 1997;3:594-7.
119. Kuo PC, Johnson LB, Plotkin JS, et al. Continuous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 1997;63:604-6.
120. Koelzow H, Gedney JA, Baumann J, et al. The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation. Anesth Analg 2002;94(4):824-9.
121. McCaulley J, Van Thiel D, Starzl TE, et al. Acute and chronic renal failure after liver transplantation. Nephron 1990;55:121.
122. Levy MF, Greene L, Ramsay MA, et al. Readmission to the intensive care unit after liver transplantation. Crit Care Med 2001;29(1):18-24.
123. Gottesdiener KM. Transplanted infections: donor-to-host transmission with the allograft. Ann Intern Med 1989;110:1001.
124. Simon DM, Levin S. Infectious complications of solid organ transplantations. Infect Dis Clin N Am 2001;15(2):521-49.
125. Dummer S, Kusne S. Liver transplantation and related infections. Semin Respir Infect 1993;8:191-8.
126. McClean K, Kneterman N, Taylor G. Comparative risk factors of bloodstream infection in organ transplant recipients. Infect Control Hosp Epidemiol 1994;15:582.
127. Linden PK, Pasculle AW, Manez R, et al. Differences in outcomes for patients with bacteremia caused by vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996;22:663.
128. Lorber B. Listeriosis. Clin Infect Dis 1997;24:1.
129. Paya CV. Fungal infections in solid organ transplantation. Clin Infect Dis 1993;16:677.
130. Guillemain R, Lavarde V, Amrein C, et al. Invasive aspergillosis after transplantation. Transplant Proc 1995;27(1):1307-9.
131. Bzeizi KI, Jalan R, Plevris JN, et al. Primary graft dysfunction after liver transplantation: from pathogenesis to prevention. Liver Transplant Surg 1997;3:137-48.
132. Abbasoglu O, Levy MF, Vodapally MS, et al. Hepatic artery stenosis after liver transplantation: incidence, presentation, treatment, and long-term outcome. Transplantation 1997;630:250-5.
133. Tzakis AG, Gordon RD, Byers W, et al. Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation 1985;40:667-71.
134. Chardot C, Herrera JM, Debray D, et al. Portal vein complications after liver transplantation for biliary atresia. Liver Transplant Surg 1997;3:351-8.
135. O'Connor TP, Lewis WD, Jenkins RL. Biliary tract complications after liver transplantation. Arch Surg 1995;130:312-7.
136. Ozaki CF, Katz SM, Monsour HP, et al. Surgical complications of liver transplantation. Surg Clin N Am 1994;74:1155-67.
137. Tabasco-Minguillan J, Jain A, Naik M, et al. Gastrointestinal bleeding after liver transplantation. Transplantation 1997;63:60-7.
138. Greif F, Bronsther OL, Van Thiel DH, et al. The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg 1994;219:40-5.